Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Biomedical Science · India · 2022-04-11

Processing Time
95 days
Decision Date
2022-04-11
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research evaluating how changes in RNA impact protein synthesis and influence the progression of health burdens including cancer, aging, and infectious diseases. He utilizes expertise in RNA folding, ribosome assembly, and protein synthesis mechanisms to identify novel therapeutic targets for these disorders.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor has broad implications for U.S. public health, particularly in cancer diagnostics and the treatment of infectious diseases like tuberculosis.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 12 years of experience, a significant citation record, and has secured funding from the NIH.

3 Waiver Benefit Met

On balance, the petitioner's contributions to RNA biology and disease treatment justify waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles with 205 citations from researchers in 30 countries. Additional evidence included 12 peer reviews for journals, 12 years of research experience, and funding from the National Institutes of Health (NIH).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Fellow

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
Maryland 65 days 2022-04-14
The petitioner proposes to continue investigating RNA and RNA-binding proteins implicated in cancer initiation and development. The work focuses on advancing cancer treatment, diagnosis, and prognosis by providing alternative treatments to chemotherapy, radiation, and surgery.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
Texas 53 days 2022-03-23
The petitioner proposes to continue using molecular cloning, protein expression and purification, and biochemistry assays to advance knowledge of the structure of cell surface receptors. Her work focuses on deepening the fundamental understanding of biological systems to pave the way for developing targeted therapeutics for diseases such as cancer.
View Case

Scientist

Biotechnology · Albania

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-10
The petitioner proposes to continue her research in molecular biology, specifically focusing on identifying drug targets and their mechanisms of action in complex biological samples. Her work utilizes proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer. This research is intended to enhance the understanding of disease mechanisms and inform the development of targeted therapies for cancer, metabolic disorders, and neurodegenerative conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 95 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist